Cargando…

National Essential Medicines List and policy practice: A case study of China’s health care reform

BACKGROUND: In 2009, China implemented the national essential medicines system by enacting the National Essential Medicines List 2009. According to the policy of this system, primary health care institutions can only stock and use essential medicines on the prescribed List. Meanwhile, each province...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Xin, Song, Yaran, Zhang, Xinping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534553/
https://www.ncbi.nlm.nih.gov/pubmed/23150933
http://dx.doi.org/10.1186/1472-6963-12-401
_version_ 1782475353590071296
author Tian, Xin
Song, Yaran
Zhang, Xinping
author_facet Tian, Xin
Song, Yaran
Zhang, Xinping
author_sort Tian, Xin
collection PubMed
description BACKGROUND: In 2009, China implemented the national essential medicines system by enacting the National Essential Medicines List 2009. According to the policy of this system, primary health care institutions can only stock and use essential medicines on the prescribed List. Meanwhile, each province can choose to make its own list of supplemented medicines. The goal of the study is to provide suggestions for emerging problems and identify future policy-making trends. METHODS: In this study, we statistically analyzed the National Essential Medicines List 2009 and lists of supplemented medicines of all 29 provinces. We also examined the rationality of such medicines based on the DELPHI method and literature review, after which we studied the provincial supplements in relation to the national essential medicines system. RESULTS: We demonstrated that the National Essential Medicines List 2009 provides a comprehensive coverage of diseases as well as reasonable varieties of drugs for their treatment. The average number of supplemented medicines in 29 provinces is 207, with each medicine included in 2.9 provincial lists on average. Only 2.6% supplemented medicines are included by more than half of the provinces (>15), indicating great regional variance. Among the 32 most frequently supplemented medicines, only 18 meet the selection principles, including two with strict usage restrictions. CONCLUSION: The structure and selection of the National Essential Medicines List 2009 are relatively reasonable. The main problems, however, include the excessive and non-scientific selection of medicines on the supplemented medicines list. The function of the provincial lists of supplemented medicines has not been achieved, which has influenced the effectiveness of the national essential medicines system in China.
format Online
Article
Text
id pubmed-3534553
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35345532013-01-03 National Essential Medicines List and policy practice: A case study of China’s health care reform Tian, Xin Song, Yaran Zhang, Xinping BMC Health Serv Res Research Article BACKGROUND: In 2009, China implemented the national essential medicines system by enacting the National Essential Medicines List 2009. According to the policy of this system, primary health care institutions can only stock and use essential medicines on the prescribed List. Meanwhile, each province can choose to make its own list of supplemented medicines. The goal of the study is to provide suggestions for emerging problems and identify future policy-making trends. METHODS: In this study, we statistically analyzed the National Essential Medicines List 2009 and lists of supplemented medicines of all 29 provinces. We also examined the rationality of such medicines based on the DELPHI method and literature review, after which we studied the provincial supplements in relation to the national essential medicines system. RESULTS: We demonstrated that the National Essential Medicines List 2009 provides a comprehensive coverage of diseases as well as reasonable varieties of drugs for their treatment. The average number of supplemented medicines in 29 provinces is 207, with each medicine included in 2.9 provincial lists on average. Only 2.6% supplemented medicines are included by more than half of the provinces (>15), indicating great regional variance. Among the 32 most frequently supplemented medicines, only 18 meet the selection principles, including two with strict usage restrictions. CONCLUSION: The structure and selection of the National Essential Medicines List 2009 are relatively reasonable. The main problems, however, include the excessive and non-scientific selection of medicines on the supplemented medicines list. The function of the provincial lists of supplemented medicines has not been achieved, which has influenced the effectiveness of the national essential medicines system in China. BioMed Central 2012-11-14 /pmc/articles/PMC3534553/ /pubmed/23150933 http://dx.doi.org/10.1186/1472-6963-12-401 Text en Copyright ©2012 Tian et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tian, Xin
Song, Yaran
Zhang, Xinping
National Essential Medicines List and policy practice: A case study of China’s health care reform
title National Essential Medicines List and policy practice: A case study of China’s health care reform
title_full National Essential Medicines List and policy practice: A case study of China’s health care reform
title_fullStr National Essential Medicines List and policy practice: A case study of China’s health care reform
title_full_unstemmed National Essential Medicines List and policy practice: A case study of China’s health care reform
title_short National Essential Medicines List and policy practice: A case study of China’s health care reform
title_sort national essential medicines list and policy practice: a case study of china’s health care reform
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534553/
https://www.ncbi.nlm.nih.gov/pubmed/23150933
http://dx.doi.org/10.1186/1472-6963-12-401
work_keys_str_mv AT tianxin nationalessentialmedicineslistandpolicypracticeacasestudyofchinashealthcarereform
AT songyaran nationalessentialmedicineslistandpolicypracticeacasestudyofchinashealthcarereform
AT zhangxinping nationalessentialmedicineslistandpolicypracticeacasestudyofchinashealthcarereform